Vitestro Raises EUR 12M in Series A Financing
- Vitestro, an Utrecht, Netherlands-based developer of an autonomous blood drawing device, raised EUR12M in Series A funding
- The round was led by Sonder Capital
- The company intends to use the funds to accelerate product development, prepare EU market authorization, and initiate production
- The company is advancing a device that combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion, ensuring accurate and secure blood collection
- A prototype has been tested on more than 1,000 patients
- Clinical studies will continue in 2023, with European market introduction anticipated in 2024
